Differential Effect of 4H-Benzo[d] [1, 3]oxazines on the Proliferation of Breast Cancer Cell Lines

Ixamail Fraire-Soto,Jorge Gustavo Araujo-Huitrado,Angelica Judith Granados-López,Luis A. Segura-Quezada,Rafael Ortiz-Alvarado,Mayra Denise Herrera,Rosalinda Gutiérrez-Hernández,Claudia Araceli Reyes-Hernández,Yamilé López-Hernández,Melissa Tapia-Juárez,José Vicente Negrete-Díaz,Luis Chacón-García,César R. Solorio-Alvarado,Jesús Adrián López
DOI: https://doi.org/10.2174/0109298673292365240422104456
IF: 4.74
2024-04-26
Current Medicinal Chemistry
Abstract:Background: A family of 4H-benzo[d][1,3]oxazines were obtained from a group of N-(2-alkynyl)aryl benzamides precursors via gold(I) catalysed chemoselective 6-exo-dig C-O cyclization. Method: The precursors and oxazines obtained were studied in breast cancer cell lines MCF-7, CAMA-1, HCC1954 and SKBR-3 with differential biological activity showing various degrees of inhibition with a notable effect for those that had an aryl substituted at C-2 of the molecules. 4H-benzo[d][1,3]oxazines showed an IC50 rating from 0.30 to 157.4 μM in MCF-7, 0.16 to 139 in CAMA-1, 0.09 to 93.08 in SKBR-3, and 0.51 to 157.2 in HCC1954 cells. Results: We observed that etoposide is similar to benzoxazines while taxol effect is more potent. Four cell lines responded to benzoxazines while SKBR-3 cell line responded to precursors and benzoxazines. Compounds 16, 24, 25 and 26 have the potent effect in cell proliferation inhibition in the 4 cell lines tested and correlated with oxidant activity suggesting a possible mechanism by ROS generation. Conclusion: These compounds represent possible drug candidates for the treatment of breast cancer. However, further trials are needed to elucidate its full effect on cellular and molecular features of cancer.
pharmacology & pharmacy,biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?